RO4917523

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for RO4917523, covering 2015-09-10 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO4917523 in Patients With Treatment Resistant Depression [Phase 2]